Terms: = Skin cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Staging
31 results:
1. Epidermotropic B-Cell Lymphoma: A Case of Secondary Cutaneous Splenic Marginal Zone B-Cell Lymphoma With Autoinvolutive and Recurrent Cutaneous Lesions.
Rovira-López R; Gallardo F; Salar A; Colomo L; Pujol RM
Am J Dermatopathol; 2023 Feb; 45(2):81-85. PubMed ID: 36669069
[TBL] [Abstract] [Full Text] [Related]
2. Primary cutaneous follicle center lymphoma with aberrant CD8 expression.
Lee J; Cohen JA; Wrone DA; Gru AA
J Cutan Pathol; 2022 Apr; 49(4):403-407. PubMed ID: 34797569
[TBL] [Abstract] [Full Text] [Related]
3. Primary cutaneous anaplastic large-cell lymphoma with aberrant cytokeratin expression: An unusual mimicker of poorly differentiated carcinomas.
Lee J; Jiang H; Gru AA
J Cutan Pathol; 2022 Mar; 49(3):306-309. PubMed ID: 34705295
[TBL] [Abstract] [Full Text] [Related]
4. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
Lyapichev KA; Bah I; Huen A; Duvic M; Routbort MJ; Wang W; Jorgensen JL; Medeiros LJ; Vega F; Craig FE; Wang SA
Cytometry B Clin Cytom; 2021 Mar; 100(2):183-191. PubMed ID: 32667737
[TBL] [Abstract] [Full Text] [Related]
5. Revisiting the initial diagnosis and blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker.
Roelens M; de Masson A; Ram-Wolff C; Maki G; Cayuela JM; Marie-Cardine A; Bensussan A; Toubert A; Bagot M; Moins-Teisserenc H
Br J Dermatol; 2020 Jun; 182(6):1415-1422. PubMed ID: 31487384
[TBL] [Abstract] [Full Text] [Related]
6. Rituximab as a therapeutic option for patients with advanced melanoma.
Winkler JK; Schiller M; Bender C; Enk AH; Hassel JC
Cancer Immunol Immunother; 2018 Jun; 67(6):917-924. PubMed ID: 29516155
[TBL] [Abstract] [Full Text] [Related]
7. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
[TBL] [Abstract] [Full Text] [Related]
8. Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
Gibson JF; Huang J; Liu KJ; Carlson KR; Foss F; Choi J; Edelson R; Hussong JW; Mohl R; Hill S; Girardi M
J Am Acad Dermatol; 2016 May; 74(5):870-7. PubMed ID: 26874819
[TBL] [Abstract] [Full Text] [Related]
9. Epidermotropic B-Cell Lymphoma: A Unique Subset of CXCR3-Positive Marginal Zone Lymphoma.
Magro CM; Momtahen S; Lee BA; Swanson DL; Pavlovic MD
Am J Dermatopathol; 2016 Feb; 38(2):105-12. PubMed ID: 26275313
[TBL] [Abstract] [Full Text] [Related]
10. Primary malignant melanoma of the breast: case report and review of the literature.
Drueppel D; Schultheis B; Solass W; Ergonenc H; Tempfer CB
Anticancer Res; 2015 Mar; 35(3):1709-13. PubMed ID: 25750332
[TBL] [Abstract] [Full Text] [Related]
11. CD8-positive peripheral T-cell lymphoma with aberrant expression of cd20 and concurrent in situ follicular lymphoma.
Sagasta A; Molina-Urra R; Martinez D; Gonzalez-Farre B; Marti E; Herranz MJ; Estrach T; Campo E; Colomo L
J Cutan Pathol; 2015 Jan; 42(1):66-72. PubMed ID: 25354337
[TBL] [Abstract] [Full Text] [Related]
12. microRNA portraits in human vulvar carcinoma.
de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM
Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714
[TBL] [Abstract] [Full Text] [Related]
13. A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts.
Meyer S; Fuchs TJ; Bosserhoff AK; Hofstädter F; Pauer A; Roth V; Buhmann JM; Moll I; Anagnostou N; Brandner JM; Ikenberg K; Moch H; Landthaler M; Vogt T; Wild PJ
PLoS One; 2012; 7(6):e38222. PubMed ID: 22685558
[TBL] [Abstract] [Full Text] [Related]
14. My treatment approach to patients with diffuse large B-cell lymphoma.
Armitage JO
Mayo Clin Proc; 2012 Feb; 87(2):161-71. PubMed ID: 22305028
[TBL] [Abstract] [Full Text] [Related]
15. Primary cutaneous B-cell lymphomas.
Kempf W; Denisjuk N; Kerl K; Cozzio A; Sander C
J Dtsch Dermatol Ges; 2012 Jan; 10(1):12-22; quiz 23. PubMed ID: 22212142
[TBL] [Abstract] [Full Text] [Related]
16. Primary cutaneous mantle cell lymphoma with blastic features: report of a rare case with special reference to staging and effectiveness of chemotherapy.
Lynch DW; Verma R; Larson E; Geis MC; Jassim AD
J Cutan Pathol; 2012 Apr; 39(4):449-53. PubMed ID: 22121909
[TBL] [Abstract] [Full Text] [Related]
17. An unusual case of cutaneous blastic plasmacytoid dendritic cell neoplasm with concomitant B-cell lymphoproliferative disorder.
Patel JL; Shetty S; Salama ME
Am J Dermatopathol; 2011 May; 33(3):e31-6. PubMed ID: 20861710
[TBL] [Abstract] [Full Text] [Related]
18. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vbeta chain antibodies and its application in blood staging.
Feng B; Jorgensen JL; Jones D; Chen SS; Hu Y; Medeiros LJ; Wang SA
Mod Pathol; 2010 Feb; 23(2):284-95. PubMed ID: 19935642
[TBL] [Abstract] [Full Text] [Related]
19. Subclinical chronic lymphocytic leukemia with atypical cutaneous presentation.
Ali L; Cheney R; Merzianu M
J Cutan Pathol; 2011 Feb; 38(2):236-40. PubMed ID: 19719832
[TBL] [Abstract] [Full Text] [Related]
20. Incidental chronic lymphocytic leukaemia in a biopsy of Merkel cell carcinoma.
Craig PJ; Calonje JE; Harries M; Stefanato CM
J Cutan Pathol; 2009 Jun; 36(6):706-10. PubMed ID: 19519600
[TBL] [Abstract] [Full Text] [Related]
[Next]
